ISSN: 1078-1439

Journal Home

Journal Guideline

Urologic Oncology: Seminars and Original Investigations Q1 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Urologic Oncology: Seminars and Original Investigations is a journal indexed in SJR in Oncology and Urology with an H index of 89. It has an SJR impact factor of 0,855 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,855.

Urologic Oncology: Seminars and Original Investigations focuses its scope in these topics and keywords: cancer, bladder, cell, men, radical, cystectomy, metastatic, patients, american, antigen, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Urology (Q1) Oncology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Urologic Oncology: Seminars and Original Investigations

0,855

SJR Impact factor

89

H Index

266

Total Docs (Last Year)

949

Total Docs (3 years)

8362

Total Refs

2216

Total Cites (3 years)

928

Citable Docs (3 years)

2.23

Cites/Doc (2 years)

31.44

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cancer Q1
JAMA oncology Q1
Journal of Thoracic Oncology Q1
Cancer Discovery Q1
Neuro-Oncology Q1

Compare this journals